Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Total 13F shares
-
161,403,124
-
Share change
-
-3,871,653
-
Total reported value
-
$1,554,306,323
-
Put/Call ratio
-
84%
-
Price per share
-
$9.63
-
Number of holders
-
246
-
Value change
-
-$46,073,363
-
Number of buys
-
108
-
Number of sells
-
135
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q3 2023
As of 30 Sep 2023,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
246 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
161,403,124 shares.
The largest 10 holders included
BlackRock Inc., Sarissa Capital Management LP, VANGUARD GROUP INC, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, CREDIT SUISSE AG/, VICTORY CAPITAL MANAGEMENT INC, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
247
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.